Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Receivables - Net: 2011-2024

Historic Receivables - Net for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $59.0 million.

  • Mimedx Group's Receivables - Net rose 47.20% to $83.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.6 million, marking a year-over-year increase of 47.20%. This contributed to the annual value of $59.0 million for FY2024, which is 3.41% up from last year.
  • Per Mimedx Group's latest filing, its Receivables - Net stood at $59.0 million for FY2024, which was up 3.41% from $57.0 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Receivables - Net ranged from a high of $59.0 million in FY2024 and a low of $36.2 million during FY2020.
  • Moreover, its 3-year median value for Receivables - Net was $57.0 million (2023), whereas its average is $54.3 million.
  • Data for Mimedx Group's Receivables - Net shows a peak YoY grew of 21.65% (in 2023) over the last 5 years.
  • Over the past 5 years, Mimedx Group's Receivables - Net (Yearly) stood at $36.2 million in 2020, then climbed by 14.88% to $41.5 million in 2021, then climbed by 12.82% to $46.9 million in 2022, then increased by 21.65% to $57.0 million in 2023, then rose by 3.41% to $59.0 million in 2024.